Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 97301-97350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04695925
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations
PHASE3Active, not recruiting
294 participants
Started: Mar 29, 2021 · Completed: Dec 30, 2027
2 conditions4 sponsors2 locations
NCT05273957
A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism.
NAActive, not recruiting
121 participants
Started: Mar 29, 2021 · Completed: Jun 30, 2025
5 conditions2 sponsors2 locations
NCT04530942
The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression
NAActive, not recruiting
34 participants
Started: Mar 29, 2021 · Completed: Dec 30, 2024
2 conditions1 sponsor1 location
NCT04709328
To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19
PHASE2/PHASE3Not yet recruiting
690 participants
Started: Mar 28, 2021 · Completed: Mar 1, 2022
2 conditions1 sponsor0 locations
NCT04750122
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients
PHASE1/PHASE2Recruiting
46 participants
Started: Mar 28, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04460040
Exercise-Induced Metabolic Compensation; a Physiological Adaptive Response to Exercise Training
NAActive, not recruiting
16 participants
Started: Mar 27, 2021 · Completed: Nov 1, 2024
1 condition2 sponsors1 location
NCT05035901
Geometric-Based Handwriting Intervention: Development, Feasibility and Randomized Clinical Trial
NARecruiting
72 participants
Started: Mar 27, 2021 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04634916
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NARecruiting
280 participants
Started: Mar 26, 2021 · Completed: Sep 30, 2026
3 conditions1 sponsor14 locations
NCT04634058
PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment
PHASE2Active, not recruiting
40 participants
Started: Mar 26, 2021 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT04959227
Investigation of Anxiety, Depression and Physical Activity Level in Whirling Dervishes
N/AEnrolling by invitation
60 participants
Started: Mar 26, 2021 · Completed: Sep 15, 2024
1 condition1 sponsor1 location
NCT04551040
Target Engagement of Terazosin in Healthy Adults
PHASE1Active, not recruiting
18 participants
Started: Mar 26, 2021 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT04954001
Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Mar 26, 2021 · Completed: Mar 30, 2025
3 conditions1 sponsor14 locations
NCT04303104
Xpert Active Case-finding Trial 3 (XACT-3)
NAActive, not recruiting
3,394 participants
Started: Mar 26, 2021 · Completed: Dec 30, 2025
1 condition7 sponsors4 locations
NCT04713345
VERARE_2 Efficacy of the Observation of Virtual Motor Actions for the Improvement of Gait in Patients With ICU-weakness
NAActive, not recruiting
68 participants
Started: Mar 26, 2021 · Completed: Sep 2, 2025
1 condition2 sponsors1 location
NCT04807803
Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension
NARecruiting
100 participants
Started: Mar 26, 2021 · Completed: Mar 25, 2025
2 conditions1 sponsor2 locations
NCT04222335
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
NARecruiting
80 participants
Started: Mar 26, 2021 · Completed: Dec 31, 2028
1 condition3 sponsors1 location
NCT05157802
Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia
PHASE1Active, not recruiting
30 participants
Started: Mar 26, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03892980
Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy
NARecruiting
145 participants
Started: Mar 26, 2021 · Completed: Dec 30, 2029
1 condition1 sponsor6 locations
NCT04607616
Interactive Guidance Therapy With Video Feed-back of Parent and Child With Autism Spectrum Disorder
NARecruiting
24 participants
Started: Mar 26, 2021 · Completed: Jan 31, 2026
1 condition2 sponsors4 locations
NCT04935164
Comparative Study of Gender Identity Disorder Versus Control
N/ARecruiting
120 participants
Started: Mar 26, 2021 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT04639414
Combined Active Treatment in Type 2 Diabetes with NASH
PHASE4Active, not recruiting
192 participants
Started: Mar 26, 2021 · Completed: Dec 31, 2025
3 conditions6 sponsors26 locations
NCT04783415
Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
PHASE2Active, not recruiting
12 participants
Started: Mar 26, 2021 · Completed: Sep 20, 2025
1 condition2 sponsors1 location
NCT05718726
Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI)
N/ARecruiting
300 participants
Started: Mar 25, 2021 · Completed: Feb 1, 2031
2 conditions1 sponsor1 location
NCT04728542
ORIGIN® vs. VANGUARD® PS Observational Study
N/ARecruiting
140 participants
Started: Mar 25, 2021 · Completed: Feb 28, 2027
3 conditions1 sponsor1 location
NCT04404153
Neurostimulation for Cognitive Enhancement in Alzheimer's Disease
NAActive, not recruiting
100 participants
Started: Mar 25, 2021 · Completed: Jan 31, 2026
2 conditions3 sponsors1 location
NCT04744428
Trial of Autism Parent Navigator Program
NAActive, not recruiting
360 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT04659811
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
PHASE2Recruiting
37 participants
Started: Mar 25, 2021 · Completed: Apr 30, 2030
4 conditions2 sponsors1 location
NCT04790474
Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib
PHASE2Active, not recruiting
61 participants
Started: Mar 25, 2021 · Completed: Sep 1, 2029
2 conditions1 sponsor7 locations
NCT04566666
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
PHASE2Active, not recruiting
263 participants
Started: Mar 25, 2021 · Completed: Apr 30, 2025
1 condition1 sponsor50 locations
NCT04845503
Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer
NAActive, not recruiting
68 participants
Started: Mar 25, 2021 · Completed: Mar 25, 2028
1 condition3 sponsors1 location
NCT04728451
Spectacle Prescribing in Early Childhood
NAActive, not recruiting
88 participants
Started: Mar 25, 2021 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT04523701
"Diagnostic Role of the White Test With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)"
PHASE3Recruiting
210 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT04199871
Improving Control of Alignment in Intermittent Exotropia
NAActive, not recruiting
84 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04195984
Mi-thos® Transcatheter Mitral Valve Replacement Study
NARecruiting
122 participants
Started: Mar 25, 2021 · Completed: Jan 31, 2027
1 condition1 sponsor3 locations
NCT04503694
Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
PHASE2Recruiting
72 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2030
2 conditions1 sponsor10 locations
NCT04499833
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma
NARecruiting
40 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2029
2 conditions2 sponsors1 location
NCT04521153
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma
PHASE2/PHASE3Active, not recruiting
294 participants
Started: Mar 25, 2021 · Completed: Mar 1, 2026
3 conditions1 sponsor1 location
NCT04699747
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
PHASE1Recruiting
60 participants
Started: Mar 25, 2021 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT04828096
Retention With Three Different Bonded Retainers a Multicenter, Randomized Controlled Trial With 5-year Follow-up
NARecruiting
324 participants
Started: Mar 25, 2021 · Completed: Sep 30, 2026
2 conditions1 sponsor2 locations
NCT04985318
Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP
N/ARecruiting
350 participants
Started: Mar 25, 2021 · Completed: Dec 12, 2034
1 condition1 sponsor1 location
NCT05035147
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
PHASE4Recruiting
934 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05012605
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
N/ARecruiting
200 participants
Started: Mar 25, 2021 · Completed: Jun 30, 2025
4 conditions1 sponsor6 locations
NCT04747626
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
NARecruiting
590 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2030
3 conditions2 sponsors1 location
NCT04681417
Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
PHASE2/PHASE3Recruiting
225 participants
Started: Mar 25, 2021 · Completed: Jan 20, 2036
1 condition2 sponsors28 locations
NCT04646902
Kynurenine/Tryptophan Ratio in Hypertension Associated to Obstructive Sleep Apnea
N/AActive, not recruiting
203 participants
Started: Mar 25, 2021 · Completed: Mar 1, 2024
1 condition6 sponsors5 locations
NCT04523688
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PHASE2Recruiting
28 participants
Started: Mar 25, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03988439
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis
PHASE4Recruiting
45 participants
Started: Mar 24, 2021 · Completed: Mar 31, 2027
1 condition1 sponsor9 locations
NCT04831138
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma
NAEnrolling by invitation
90 participants
Started: Mar 24, 2021 · Completed: Mar 24, 2027
1 condition1 sponsor1 location
NCT04772183
OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood Gase
N/ARecruiting
300 participants
Started: Mar 24, 2021 · Completed: Jun 30, 2025
3 conditions1 sponsor2 locations
NCT04701242
"Ezetimibe Utilization Early After Acute Myocardial Infarction, EzAMI Trial"
NARecruiting
500 participants
Started: Mar 24, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location